Physician profile
Areeba Ahmed
NPI 1528459484
$3,464.60
in general payments reported to CMS, 2019-2025
18 companies · $424 in 2025
The $424 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $835 · 2022: $1,458 · 2023: $364 · 2024: $385 · 2025: $424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $965 · Travel and Lodging: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $965.02 |
| Travel and Lodging | $206.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novastep INC. | $859.93 | 2022 | |
| Zimmer Biomet Holdings, INC. | $658.66 | 2021 | |
| Treace Medical Concepts, INC. | $514.75 | 2022-2023 | |
| Rattan and Associates | $324.99 | 2025 | |
| Stryker Corporation | $195.64 | 2024-2025 | Infinity Adaptis, Infinity, Inbone |
| Bard Peripheral Vascular, INC. | $149.99 | 2024 | Rotarexs 6 F X 135 Cm |
| Horizon Therapeutics Plc | $127.20 | 2021 | |
| Novo Nordisk INC | $124.46 | 2023 | Wegovy |
| Acera Surgical, INC. | $121.73 | 2022-2023 | Restrata Wound Matrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $114.03 | 2024 | Jardiance |
| Smith+Nephew, INC. | $78.48 | 2022-2023 | Collagenase Santyl, Regranex |
| Kerecis Limited | $61.06 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Bioventus LLC | $30.11 | 2021 | |
| Urgo Medical North America, LLC | $23.72 | 2024 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Integra Lifesciences Corporation | $22.28 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $20.00 | 2022 | |
| Abbott Laboratories | $19.04 | 2022 | |
| Organogenesis INC. | $18.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Areeba Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.